[The therapeutic effect of nitromint retard on patients with stable angina pectoris].
The antianginal [correction of antidiagnose] efficacy of nitromint retard was studied in 62 middle aged patients with angina pectoris in a 4 week treatment with a 24 h dose of 2.6 mg. Bicycle ergometry [correction of A veloergometria] was conducted before the treatment and at the end of the fourth week. The average number of anginal attacks decreased from 4.0 +/- 1.9 to 1.6 +/- 1.3 during the first week and to 0.0 +/- 0.7 at the end of the 3rd week. The average threshold power increased at the end of the 4th week. Nitromint retard increased considerably the tolerance to physical load and did not increase the consumption of oxygen. The desired effect was achieved in 66.13% of the patients.
Tsekov
Kh
Kh
Karastatev
D
D
Mazhdrakova
D
D
Georgieva
Zh
Zh
Ginkova
Ia
Ia
Todorov
B
B
Dermendzhieva
R
R
Rangochev
B
B
D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005080:Exercise Test; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use*; D010807:Physical Endurance / Q000187:drug effects; D013607:Tablets; D013997:Time Factors
D003692:Delayed-Action Preparations; D013607:Tablets; D005996:Nitroglycerin
Lecheben efekt ot nitromint retard pri bolni ot stabilna angina pectoris.